Munich, Germany – August 6, 2002 – Bicoll Biotechnology (Shanghai) Co. Ltd., a 100% subsidiary of Bicoll GmbH, Germany, has successfully completed the Chinese company’s build-up process in
Shanghai / P.R. China within one year only. The general manager of Bicoll Biotechnology (Shanghai)
Co. Ltd., Dr. Kai Lamottke, is highly satisfied about the prompt implementation of the company’s
proprietary technology platform. First products have already been launched into exclusive co-
operations and partnerships. Within the next three years, Bicoll Biotechnology (Shanghai) Co. Ltd. is
planning to extend the company’s research and development location from up to date 10 employees to
over 50.